Metabolomic Discoveries GmbH
Dr. Nicolas Schauer, CEO, has a track-record of over ten years in metabolomics and biochemistry. He started his career in 2003 with a PhD at the Max-Planck-Institute of Molecular Plant Physiology in Golm, Germany. In 2009, he started Metabolomic Discoveries GmbH. A company providing metabolomics and pattern recognition approaches in medicine and diagnostics. The goal of Metabolomic Discoveries is to develop products empowering the pharma industry and the individual to improve life quality and well-being. The company developed and introduced the first @home sampling consumer metabolomics test, Kenkodo.
Big Data in Personalized Metabolomics
The human metabolism is a complex interplay of metabolites produced by the body and taken up from the environment. Our body generates energy from food and extracts essential nutrients, like vitamins or amino acids. Food, drinks, nutritional supplements, exercise and other lifestyle parameters have a large impact on our body. Today, many of these parameters can be tracked using mobile applications. We have build a platform that aims at better understanding metabolism based on a drop of blood taking at home – Kenkodo. Kenkodo allows the analysis of thousands of metabolites. By this, a huge amount of data is generated and brought into relationship with user lifestyle data monitored using mobile sensors and user feedback. Which allows to identify deficencies, undiagnosed diseases and lifestyle influences. Using metabolomics and meta-data novel biomarkers and predictors are developed by longitudinal data.
- 11:45 am- 1:15 pm: REGIONAL SESSION I: BIOTECH & PHARMA
Location: Stage 2